No inhibition of cytochrome P450 activities in human liver microsomes by sulpiride, an antipsychotic drug

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 1, 2005, Pages 188-191

  Niwa, Toshiro ^a   Inoue, Sachiko ^b   Shiraga, Toshifumi ^a   Takagi, Akira ^a  

^a ASTELLAS PHARMA INC   (Japan)

^b Fujisawa Technical Services Co Ltd   (Japan)

Author keywords

Antipsychotic drug; Cytochrome P450; Drug interaction; Human liver microsomes; Sulpiride

Indexed keywords

CHLORZOXAZONE; CIMETIDINE; CYTOCHROME P450; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; DEBRISOQUINE; DRUG METABOLIZING ENZYME; ETHOXYRESORUFIN DEETHYLASE; FLUVOXAMINE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HYDROXYCORTICOSTEROID; NEUROLEPTIC AGENT; NIFEDIPINE; OLANZAPINE; SULPIRIDE; ENZYME INHIBITOR;

ARTICLE; BIOAVAILABILITY; CATALYSIS; DRUG EFFECT; DRUG INHIBITION; DRUG SELECTIVITY; HUMAN; HUMAN CELL; HYDROXYLATION; LIVER MICROSOME; METABOLIC INHIBITION; OXIDATION; ULTRACENTRIFUGATION; COMPARATIVE STUDY; DRUG ANTAGONISM; ENZYMOLOGY; METABOLISM;

ANTIPSYCHOTIC AGENTS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; HUMANS; MICROSOMES, LIVER; SULPIRIDE;

EID: 18444387974     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.188     Document Type: Article

References (29)

1. Gonzalez F. J., Pharmacol. Ther., 45, 1-38 (1990).
2. Guengerich F. P., FASEB J., 6, 745-748 (1992).
3. Rendic S., Drug Metab. Rev., 34, 83-448 (2002).
4. Lin J. H., Lu A. Y. H., Clin. Pharmacokinet., 35, 361-390 (1998).
5. Huang S.-M., Lesko L. J., Williams R. L., J. Clin. Pharmacol., 39, 1006-1014 (1999).
6. Caley C. F., Weber S. S., Ann. Pharmacother., 29, 152-160 (1995).
7. Mauri M. C., Bravin S., Bitetto A., Rudelli R., Invernizzi G., Drug Saf., 14, 288-298 (1996).
8. Imondi A. R., Alam A. S., Brennan J. J., Hagerman L. M., Arch. Int. Pharmacodyn., 232, 79-81 (1978).
9. Chen I.-J., Yang J.-M., Ding N.-C., Jang H. R., Tsay Y.-S., Kaohsiung J. Med. Sci., 5, 222-230 (1989).
10. Bressolle F., Bres J., Faure-Jeantis A., J. Pharm. Sci., 81, 26-32 (1992).
11. Wiesel F.-A., Alfredsson G., Ehrnebo M., Sedvall G., Eur. J. Clin. Pharmacol, 17, 385-391 (1980).
12. Lerner V., Libor I., Kotler M., Strous R. D., Prog. Neuro- Psychopharmacol. Biol. Psychiatry, 28, 89-98 (2004).
13. Kotler M., Strous R. D., Reznik I., Shwartz S., Weizman A., Spivak B., Int. Clin. Psychopharmacol., 19, 23-26 (2004).
14. Murakami M., Pharma Medica, 22, 97-102 (2004).
15. Kawakami S., Sasaki D., Baba T., Yoshida Y., Okamoto K., Takahashi S., Yamagata A., Segawa M., Tsuge M., Tanabe K., Aizawa M., Takagi N., Nara H., Fukushi K., Higuchi S., Kanazawa T., Seino Y., Soma S., Higuchi K., Med. Consult. New Remedies, 25, 1755-1762 (1988).
16. Margolis J. M., Obach R. S., Drug Metab. Dispos., 31, 606-611 (2003).
17. Niwa T., Shiraga T., Hashimoto T., Kagayama A., Biol. Pharm. Bull., 27, 97-99 (2004).
18. Niwa T., Shiraga T., Hashimoto T., Kagayama A., Biol. Pharm. Bull., 27, 415-417 (2004).
19. Niwa T., Shiraga T., Yamasaki S., Ishibashi K., Ohno Y., Kagayama A., Xenobiotica, 33, 717-729 (2003).
20. Serardic D., Boobis A. R., Muurray B. P., Segura M. J., De La Torre R., Davis D. S., Br. J. Clin. Pharmacol., 29, 651-663 (1990).
21. Newton D. J., Wang R. W., Lu A. Y. H., Drug Metab. Dispos., 23, 154-158 (1995).
22. Chauret N., Gauthier A., Martin J., Nicoll-Griffith D. A., Drug Metab. Dispos., 25, 1130-1136 (1997).
23. Back D. J., Tjia J. F., Karbwang J., Colbert J., Br. J. Clin. Pharmacol., 26, 23-29 (1988).
24. Baldwin S. J., Bloomer J. C., Smith G. J., Ayrton A. D., Clarke S. E., Chenery R. J., Xenobiotica, 25, 261-270 (1995).
25. Otton S. V., Crewe H. K., Lennard M. S., Tucker G. T., Woods H. F., J. Pharmacol. Exp. Ther., 247, 242-247 (1988).
26. Ikeda T., Nishimura K., Taniguchi T., Yoshimura T., Hata T., Kashiyama E., Kudo S., Miyamoto G., Kobayashi H., Kobayashi S., Okazaki O., Hakusui H., Aoyama E., Yoshimura Y., Yamada Y., Yoshikawa M., Otsuka M., Niwa T., Kagayama A., Suzuki S., Satoh T., Xenobio. Metab. Dispos., 16, 115-126 (2001).
27. Ito K., Iwatsubo T., Kanamitsu S., Ueda K., Suzuki H., Sugiyama Y., Pharmacol. Rev., 50, 387-411 (1998).
28. Ito K., Iwatsubo T., Kanamitsu S., Nakajima Y., Sugiyama Y., Ann. Rev. Pharmacol. Toxicol., 38, 461-499 (1998).
29. Alam A. S., Imondi A. R., Udinsky J., Hagerman L. M., Arch. Int. Pharmacodyn., 242, 4-13 (1979).